68
LTU Six Sigma Group Project TRI-CORE MEDICAL LABORATORIES Six Sigma Black Belt Candidates: Sample Project Lawrence Technological University April 14-15 th , 2012

LTU SIX SIGMA - Gary Kapanowskigarykapanowski.com/wp-content/uploads/2014/08/... · LTU Six Sigma Group Project ... Customer W 5 7 9 9 3 3 Process Outputs ... Implement quarterly

  • Upload
    voduong

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

LTU Six Sigma Group Project

TRI-CORE MEDICAL LABORATORIES

Six Sigma Black Belt Candidates:

Sample Project

Lawrence Technological University

April 14-15th , 2012

Tri-Core Medical Background

2

Founded: 1998

Number of Employees: Approximately 1,100

Headquarters: Albuquerque, New Mexico

Revenue: Approximately $2.3B

Areas of Focus: Blood Bank / Transfusion Medicine,

Chemistry, Coagulation, Cytogenetics, Cytopathology,

Dermatopathology, Endocrinology, General Surgical

Pathology, Genetics, Hematology, Hematopathology,

Immunogenetics, Immunohistochemistry, Oncology,

Immunology/Autoimmune, Infectious Diseases, Toxicology,

Renal Pathology, Transplantation

Tri-Core Medical Background

Vision:

To be the laboratory of choice through personal

commitment to excellence in patient care.

Mission:

Tri-Core leads the region in providing comprehensive

laboratory information of exceptional quality and value.

Leadership is achieved by dedicated people who support

innovation, advanced technology, customer service,

education and research.

Values:

Integrity, Compassion, Accountability, Respect,

Excellence

3

4

Project Goals:

(1) To understand and improve blood draw

operations and eliminate the high amount of

variance.

(2) To improve patient/doctor delivery time for

results .

Mr. Antonis - Tri-Core Medical - Director of Laboratory Services

offered the following comments:

“We do not have a good way to schedule appointments.”

“Many of our draws take too long and back us up.”

The Problem Statement

5

Tri-Core operates twelve laboratories with

identical equipment, personnel, and runs nearly

identical blood testing on a near-identical

patient population. Though designed to perform

at similar levels, there is a variance of as many

as 401 fewer blood draws per month from the

lowest producing lab to the highest. Annually,

this is creating a potential loss of approximately

31,092 blood draws overall.

Lab 5

Other

11 Labs

Key Laboratory Operations Data

Tri-Core Labs are conducting three different levels of

tests. These tests pay between $150-$250/test. For

the purposes of our calculations we used an average

of $200/test.

All labs run ten hours for six days a week, with one

hour for lunch and two fifteen minute breaks. This

equals 8½ hours/day of working time. With three lab

personnel (receptionist/two lab technicians) a total of

1530 minutes/day.

Average blood draw process time used is 23 minutes

– Upper Specification Limit (USL).

Labs on average operate 24 days/month; resulting

288 days/year/lab.

6

Financial Impact

Lost Revenue:

The current operation yields 141,708 blood draws/year

across all twelve laboratories, this is resulting in

$28,341,600/year.

If all twelve laboratories were performing at the level

of laboratory five (172,800 blood draws/year), revenue

would increase to $34,560,000/year.

Bottom Line: A potential loss of $6,218,400/year.

Note: A 50% improvement in blood draw throughput will

yield an increase in revenue of $3,109,200 / year.

7

8

Key Six Sigma Project Tools

Historical Data Tri-Core Medical provided us with data based on sign-in

sheets for 2010.

This data was verified against weekly lab output studies.

No significant difference was observed between weekly

detail data and monthly high level data.

Monthly high level data accurately represents output of all

laboratories.

9

Labs (level 1 & 2 blood draws) Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Averages

Lab 5 1188 1200 1209 1204 1210 1200 1196 1212 1206 1194 1190 1191 1200

Lab 8 890 882 880 882 882 870 876 880 885 878 880 875 880

Lab 12 1089 1088 1089 1087 1088 1089 1089 1091 1091 1089 1089 1089 1089

Weekly

data Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12

Week 1 308 221 299 308 217 287 328 223 297

Week 2 289 216 260 296 223 266 292 221 260

Week 3 311 227 251 293 225 260 280 226 254

Week 4 302 218 278 309 220 278 290 210 278

Total 1210 882 1088 1206 885 1091 1190 880 1089

ACTUALS SAMPLE DATA (Count is based on sign-in sheets for 2010)

WEEKLY DATA

NovSeptMay

Measurement System

Things that were not considered relevant to the measurement system

included - laboratory layout and patient demographics. The following

Cause & Effect Matrix was created and used to identify those

variables important for further review and analysis.

10

Rating of Importance to

Customer →5 7 9 9 3 3

Process Outputs (Effects) → 1 2 3 4 5 6

Process Inputs (Causes) ↓ Next

day s

chedule

Confirm

tT

est

/ P

ull

patient

chart

Blo

od d

raw

Testing r

eport

Lab c

leaned f

or

next

patient

Lab r

e-s

tocked a

nd

pre

pped f

or

next

day

Total

Receptionist duties 9 9 3 7 7 9 2463 Different lab processes 7 3 7 5 7 7 206Receptionist's skill set & education 5 7 3 3 5 5 158Patient demographics 3 3 5 3 3 3 126Laboratory layout 3 3 3 3 3 3 108

Tri-Core Cause & Effect Matrix

Note: scoring scale using 3, 5, 7, and 9.

Graphical Analysis

Different types of analysis tools were used to help

determine which variables (X’s of interest) should be

pursued and data collected. The following chart shows in

those input variables (X’s) and their respective order of

importance .

11

12

Graphical Analysis

Statistical Approach

Several different types of statistical methods were used to

determine critical inputs and root causes. The results from

an ANOVA is highlighted below.

ANOVA was used to determine if a difference existed

between the three different blood draw processes. Actual

sample data was used.

13

The Result: we accept Ha and reject Ho

Since Fobs (9957) is > Fcrit (3.29) [p=0], reject Ho and conclude that the

differences in blood draw processes does increase total blood draw

throughput.

Analyses Summary

It was determined through observation, FMEA and Takt

time analysis that the Receptionist /Lab Technician

duties in laboratory five played a significant role in the

blood draw throughput.

The balance of our time was spent on the following

activities: Establishing daily blood draw targets

Developing a Pilot Test program

Implementing Process Control procedures, including control charts

Review all recommended changes with Mr. Antonis –Director of

Laboratory Services

14

Blood Draw Target:

The target for the lab processes is to increase the blood

draws performance from 11,809 / month to 14,400 / month

(theoretical max. 19,152 / month), while increasing the

number of personnel active in the process from two to three

persons (Receptionist will help the Lab technicians in the

overall blood draw process).

The blood draws/day values are the following:

- Other 11 Labs: 40.1

- Lab 5: 50.0

- Ideal Lab: 66.5

15

Establishing The Targets

An initial goal of 45 blood draws/day/lab; results in a

50% improvement !

ESTABLISHING THE TARGETS

16

Improve Laboratories Performance

0

10

20

30

40

50

60

70

Other 11 Labs Lab 5 Ideal Lab

40.1

50

66.5

2 3 3

Blood draws / day

Number of personnel

The initial goal is to move

the average daily blood

draw to 45 resulting in a

50% improvement

Pilot Program

Pick one lab other than Lab 5 (e.g. Lab 9), for a pilot program

and ask the Receptionist/Lab tech to shadow the Lab 5

Receptionist /Lab tech for one week to observe their day-to-

day operation.

This enhanced role for the Receptionist/Lab tech should be

put into practice for one month to determine the change in

blood draw throughput.

Chart the number of daily blood draws for one month in the

pilot lab.

If pilot program is successful, implement this new process in

the other 10 laboratories and chart the results for 3 months.

Review results with Tri-Core Medical Director and Six Sigma

Black Belt team to determine rate of improvement and

compare to baseline.

17

Developing Potential Solutions

Process Control Plan

1. Observe and document Lab 5 Receptionist and Lab

technician duties/responsibilities. Update employee

handbook and job description with these improvements.

2. Train all receptionists and lab technicians from the other

10 labs with these enhanced duties, and monitor blood

draw throughput (see page 68 for detailed receptionist’s

work instructions).

3. Standardize all lab operating procedures for Tri-Core

Medical on a company wide basis.

4. Create a daily patient blood draw completions database

system to monitor performance.

18

Process Control Plan (continued)

19

5. Monitor all Labs utilizing a control chart (see example

page 64).

6. Implement quarterly meetings (Kaizen), to determine if

other cost saving/employee efficiency suggestions should

be added to Tri-Core Medical processes/procedures

manual.

7. Reward top 2 Labs (e.g. small bonus, vacation time, etc.)

every month based on superior performance.

8. If necessary, change the Receptionist position description

to include medical assistant training and/or experience.

20

1. Improve as quickly as possible 11 Tri-Core Medical Laboratories with

reduced blood draw throughput.

2. Investigate 3 different laboratory blood draw processes for takt time

and operational efficiency.

3. Identify all reasons that cause Lab 5 throughput to be significantly

higher than the other laboratories.

4. Quickly standardize Lab 5 Receptionist/Lab technician duties and

responsibilities for all other labs.

5. Develop new monthly blood draw baseline for all labs to achieve, and

monitor their behavior with new control chart.

6. Document and standardize Tri-Core Medical employee handbook

with new Receptionist/Lab technician enhanced duties and

responsibilities, and hiring requirements if necessary.

Tri-Core Medical Project Summary

Back-up Slides: Tri-Core Medical

Six Sigma Project

DEFINE Phase: slides 22 - 30

MEASURE Phase: slides 31 - 46

ANALYZE Phase: slides 47 - 54

IMPROVE Phase: slides 55 - 62

CONTROL Phase: slides 63 - 68

21

Project Charter

22

Project Name Tri-Core Medical Laboratories Business / Location Albuquerque, NM

Green Belt Jim Steiger Telephone Number 810-227-1638

Black Belt Telephone Number

Champion Yolanda Ntseful Telephone Number 248-204-4050

Start Date: July 25, 2011 Target End Date: Dec 6, 2011

Project Details

Project Description To improve the throughput in monthly blood draw performance by determining the cause of the differences among laboratories. This will improve the overall blood draw process and patient/doctor delivery time. This project is Critical To Delivery (CTD).

Business Case Tri-Core Medical Labs is losing on average $200 per blood draw in lost opportunities across 11 of their 12 laboratories. If all labs were performing at the rate of Lab 5, the increase in revenue $11,404,800/year.

Problem Statement Tri-Core Laboratories is conducting 141,708 blood draws/year out of 172,800 blood draws/year, leading to a loss of 31,092 blood draws/year, costing an average of $6,218,400/year.

Process & Owner Blood Draw Operational process – Laboratory Director – Mr. Antonis

Scope Start: Stop: Includes: Excludes:

Pre-24 hour advance call to patient Next day’s lab preparation Patient arrival and check-in; Blood draw completion (Level 1, Level 2); Blood sample processing Blood draw completion (Level 3), performed by two external labs (at hospital facilities)

Project Goals Metric Baseline Current Goal Theoretical Max.

Increase blood draw performance

Blood Draws /month 11,809 blood draws/month

across 12 labs

11,809 blood draws/month

across 12 labs

14,400 blood draws/month

across 12 labs

19,152 blood draws/month across

12 labs

Expected Business Results

Increase blood draws by 50%

Increase blood draws by 90%

Expected Customer Benefits

Improve the patient/doctor delivery time for results.

Team members Radu Muresan

Support Required Tri-Core Medical HR Manager/Director, along with Mr. Antonis – Lab Director Lab 5 Receptionist

Risks or Constraints The fear of change by some receptionists with enhanced duties.

Findings and Action Plan

Title: Tri-Core Medical Six Sigma Project JPS

Background

Current Situation

Goal

Analysis

Recommendations

Plan

Follow - up

Tri-Core Medical Laboratories is experiencing

significantly different monthly blood draw

throughput among its 12 labs.

The Laboratory Director wants us to investigate

the cause for the laboratory variance.

Bring the other 11 labs in-line with Lab 5.

Identify possible causes and determine how best to

correct the problem quickly.

It was determined through our analyses that the

Receptionist duties and responsibilities are the

leading cause for differences in blood draw

throughput among Tri-Core Medical Labs.

1st – Expand the roles & responsibilities of the

Receptionist/Lab tech in the other 11 labs.

2nd - Explore streamlining the Lab tech’s duties to

determine if the overall laboratory process can be

improved.

Pick one lab Receptionist (other than lab 5) in a pilot

program and ask the Receptionist/Lab tech to shadow

the Lab 5 Receptionist/Lab tech for one week to

observe their day-to-day operation. Then this

enhanced role for the Receptionist/Lab tech needs to

be put into practice for one month to determine the

change in results.

After one month, analyze the data for improvements. If

successful, implement this process among the other 10

labs as quickly as possible. After 3 months, re-analyze

the data from the other 11 labs to determine the

improvement. Personnel changes may be necessary if

desired results are not meeting expectations.

Tri-Core Medical Labs has identified 3 different

operational processes being used among their labs.

23

Key Assumptions:

1. Labs run at 6 days/week; 10 hours /day. 1 hour for lunch, and two15 min

breaks = 8.5 hours/day of working time. With 3 lab personnel = 1530

minutes/day.

2. Average blood draw process time used is 23 minutes.

3. Labs on average operate 24 days/month (taking into account

longer/shorter months & holidays)

4. Total working days/year/lab = 288.

5. Average lab test pays $200.

Lost Opportunities:

1. 1530 min/day (3 lab personnel) divided by 23 minutes/blood draw

process = 66.5 blood draws/day “in a perfect world “= 1596/month

(Theoretical Maximum).

2. Currently Lab 5 is operating at 50 blood draws/day = 1200/month

(Pacesetter).

3. Other 11 Labs are averaging 40 blood draws/day = 960/month (Current

Level)

4. Lost opportunities vs. Pacesetter = 1596 – 1200 = 396/month

5. Lost opportunities vs. current (except Lab 5) = 1596 – 960 =

636/month/lab

24

Key Assumptions and COPQ

25

Cost of Poor Quality (COPQ):

1. Lab 5 – 396/month x 12 months x 1 lab x $200/test = $950,400/year

2. Other 11 Labs – 636/month x 12 months x 11 labs x $200/test =

$16,790,400/year

3. Total COPQ under current conditions = $950,400 + $16,790,400 =

$17,740,800/year

Note: If all Labs were running like Lab 5 the COPQ would be

reduced to $11,404,800/year

Key Assumptions and COPQ

The COPQ from lost opportunities = $17,740,800/year

Define the Process

26

Supplier Input Process Output Customer

WHO are your

primary

customers?

WHAT does the

customer

receive? (Think of

their CTD’s)

What STEPS are Included

in the Process today?

(high level)

What is

provided to

START the

process?

Who

PROVIDES

the input?

(Who) (Nouns) (Verbs) (Nouns) (Who)

24 hour advance call to patients

Patient arrival & check-in by receptionist

Patient blood draw by lab tech1

Analyses of Blood by lab tech 2 & report sent to Doctor

Lab area prepared for next patient by lab tech 1

Prep for next days patients by all lab personnel

Instrument

Manufacturers

Computer

Manufacturers

Medical Supply

Company

Phone Company

Medical Disposal

Company

Receptionist

Lab Technicians

Completed

Analyses

Electronic

Reporting

Filled Blood Vials

Patient

Communication

Removal of Medical

Waste Bins

Prepare Lab for

next Days’

Schedule

Blood Analyses

Reports; prep for

next day

Lab Technicians

All Lab Personnel

All Lab Personnel

Patients & Lab

Personnel

All Lab Personnel

Patients

Patients & Doctors

DEFINE

Analysis Instruments

Computers &

Printers

Syringes, Alcohol,

Cotton Swabs

Phones, Answering

Machine

Medical Waste Bins

Patient Scheduling

and Log-in

Blood Draws,

Specimen Vials

27

DEFINE

28

DEFINE

29

DEFINE

30

DEFINE

MEASURE

31

Note: scoring scale using 3, 5, 7, and 9.

Rating of Importance to

Customer →5 7 9 9 3 3

Process Outputs (Effects) → 1 2 3 4 5 6

Process Inputs (Causes) ↓ Next

day s

chedule

Confirm

tT

est

/ P

ull

patient

chart

Blo

od d

raw

Testing r

eport

Lab c

leaned f

or

next

patient

Lab r

e-s

tocked a

nd

pre

pped f

or

next

day

Total

Receptionist duties 9 9 3 7 7 9 2463 Different lab processes 7 3 7 5 7 7 206Receptionist's skill set & education 5 7 3 3 5 5 158Patient demographics 3 3 5 3 3 3 126Laboratory layout 3 3 3 3 3 3 108

Tri-Core Cause & Effect Matrix

32

MEASURE

RPN Scoring used for PFMEA

Example of a scoring scale using 1, 3, 6, and 9.

Designed to achieve a greater spread when rating severity, occurrences

and detection categories of a Failure Modes & Effects Analysis.

Rating Severity of Effect Likelihood of Occurrence Ability to Detect

9 Hazardous defect noticed by all customers Failure is inevitable Can not detect

6 Major defect noticed by most customers Frequent failures Moderate chance of detection

3 Minor defect noticed by some customers Relatively few failures High chance of detection

1 No effect Failure is unlikely Certain detection

33

MEASURE

34

Labs (level 1 & 2 blood draws) Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Process

Lab 1 1100 1100 1100 1100 1100 1100 1100 1100 1100 1100 1100 1100 B

Lab 2 900 900 900 900 900 900 900 900 900 900 900 900 A

Lab 3 910 910 910 910 910 910 910 910 910 910 910 910 A

Lab 4 800 800 800 800 800 800 800 800 800 800 800 800 A

Lab 5 1200 1200 1200 1200 1200 1200 1200 1200 1200 1200 1200 1200 C

Lab 6 1114 1114 1114 1114 1114 1114 1114 1114 1114 1114 1114 1114 B

Lab 7 900 900 900 900 900 900 900 900 900 900 900 900 A

Lab 8 880 880 880 880 880 880 880 880 880 880 880 880 A

Lab 9 799 799 799 799 799 799 799 799 799 799 799 799 A

Lab 10 1008 1008 1008 1008 1008 1008 1008 1008 1008 1008 1008 1008 B

Lab 11 1109 1109 1109 1109 1109 1109 1109 1109 1109 1109 1109 1109 B

Lab 12 1089 1089 1089 1089 1089 1089 1089 1089 1089 1089 1089 1089 B

HISTORICAL DATA (YEAR 2010)

MEASURE

35

Labs (level 1 & 2 blood draws) Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Averages

Lab 5 1188 1200 1209 1204 1210 1200 1196 1212 1206 1194 1190 1191 1200

Lab 8 890 882 880 882 882 870 876 880 885 878 880 875 880

Lab 12 1089 1088 1089 1087 1088 1089 1089 1091 1091 1089 1089 1089 1089

Weekly

data Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12

Week 1 308 221 299 308 217 287 328 223 297

Week 2 289 216 260 296 223 266 292 221 260

Week 3 311 227 251 293 225 260 280 226 254

Week 4 302 218 278 309 220 278 290 210 278

Total 1210 882 1088 1206 885 1091 1190 880 1089

ACTUALS SAMPLE DATA (Count is based on sign-in sheets for 2010)

WEEKLY DATA

NovSeptMay

MEASURE

36

Process A Process B Process C

Blood Draw Differences 864 1084 1200

0

200

400

600

800

1000

1200

1400

Ave

rag

e N

um

be

r o

f B

loo

d D

raw

s p

er

Mo

nth

Blood Draw Differences

MEASURE

PERFORMANCE STANDARDS

The specification:

Taking into account the initial data received from the

management of Tri-Core Medical Laboratories, we have

the following:

50% Level 1 tests/lab (20 min/test) ;

30% Level 2 tests/lab (30 min/test);

20% Level 3 tests/lab (20 min/test).

The specification against every improvement will be

compared was calculated at the following value: USL= 23

min/test (for this process there is no LSL).

37

MEASURE

MSA – GAGE R & R

Discrete (Attribute) Data:

The Actual Sample Data, from Tri-Core Medical Laboratories

will be used to perform the Gage R&R (Attribute Agreement

Analysis); only a minimum score of 80 % is acceptable.

The initial set-up conditions:

3 appraisers used (Receptionist, Lab tech 1, Lab tech 2);

3 trials were performed;

36 items were inspected: the monthly data for the Lab 5

Lab 8, and Lab 12 (counting the patients);

2 standards accepted : “Good” (patient have the test);

“Bad”(patient miss the test).

38

MEASURE

39

MEASURE

40

Lab tech 2Lab tech 1Receptionist

100

80

60

40

20

0

Appraiser

Pe

rce

nt

95.0% C I

Percent

Lab tech 2Lab tech 1Receptionist

100

80

60

40

20

0

Appraiser

Pe

rce

nt

95.0% C I

Percent

Date of study: 09/03/2011

Reported by: Radu Muresan

Name of product: Blood draw process

Misc: TRI-CORE Medical Laboratories

Assessment Agreement

Within Appraisers Appraiser vs Standard

MEASURE

MSA – GAGE R & R

Conclusions:

The minimum score of 80 % is acceptable, after performing the

analysis we obtained a score of 92.02 % , and a Kappa

coefficient of 1 (minimum acceptable is 0.9).

The Gage R&R was successful, therefore we can trust and

use with confidence the historical data from Tri-Core Medical

Laboratories.

41

MEASURE

PROCESS CAPABILITY (BASELINE)

The initial data:

For each laboratory there are employed 3 people:

Receptionist, Lab tech 1, Lab tech 2.

Working schedule is: 6 days / week, with 1 shift of 10

hours / day (1 hour for lunch time, and 2 breaks of 15

minutes / day are allowed).

The effective time of work: 8.5 hours / day / employee,

25.5 hours / day / lab, 1530 minutes / day / lab.

42

MEASURE

PROCESS CAPABILITY

43

Lab Type of Draws / Max. expected Actual Missing DPMO Current

number process month draws / day draws / day opportunities / lab / day per lab σ level

L 1 B 1100 66.5 45.8 20.7 311,278.2 1.992

L 2 A 900 66.5 37.5 29.0 436,090.2 1.661

L 3 A 910 66.5 37.9 28.6 430,075.1 1.676

L 4 A 800 66.5 33.3 33.2 499,248.1 1.502

L 5 C 1200 66.5 50.0 16.5 248,120.3 2.180

L 6 B 1114 66.5 46.4 20.1 302,255.6 2.018

L 7 A 900 66.5 37.5 29.0 436,090.2 1.661

L 8 A 880 66.5 36.6 29.9 449,624.0 1.627

L 9 A 799 66.5 33.2 33.3 500,751.8 1.498

L 10 B 1008 66.5 42.0 24.5 368,421.0 1.836

L 11 B 1109 66.5 46.2 20.3 305,263.1 2.009

L 12 B 1089 66.5 45.3 21.2 318,796.9 1.971

MEASURE

44

MEASURE

COST OF POOR QUALITY (COPQ)

45

Lab Type of Draws / Max. expected Actual Missing Avg. value COPQ

number process month draws / day draws / day opportunities / lab / day per test [ $ ] [ $ / month ]

L 1 B 1100 66.5 45.8 20.7 200 99,360

L 2 A 900 66.5 37.5 29.0 200 139,200

L 3 A 910 66.5 37.9 28.6 200 137,280

L 4 A 800 66.5 33.3 33.2 200 159,360

L 5 C 1200 66.5 50.0 16.5 200 79,200

L 6 B 1114 66.5 46.4 20.1 200 96,480

L 7 A 900 66.5 37.5 29.0 200 139,200

L 8 A 880 66.5 36.6 29.9 200 143,520

L 9 A 799 66.5 33.2 33.3 200 159,840

L 10 B 1008 66.5 42.0 24.5 200 117,600

L 11 B 1109 66.5 46.2 20.3 200 97,440

L 12 B 1089 66.5 45.3 21.2 200 101,760

MEASURE

46

MEASURE

ANALYZE

47

SAMPLING PLAN

48

WEEKLY DATA

Weekly May Sept Nov

data Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12 Lab 5 Lab 8 Lab 12

Week 1 308 221 299 308 217 287 328 223 297

Week 2 289 216 260 296 223 266 292 221 260

Week 3 311 227 251 293 225 260 280 226 254

Week 4 302 218 278 309 220 278 290 210 278

Total 1210 882 1088 1206 885 1091 1190 880 1089

ANALYZE

POTENTIAL “X” MATRIX

49

Key process inputs (X's) Origin Appropriate Result Is input vital ?

test / analysis (Yes / No)

X1 Receptionist duties Fishbone Chart FMEA RPN=729 Yes

X2 Three different lab processes Process Map 2 Sample t-test p-value = 0.0 Yes

X3 Patient scheduling C&E Matrix FMEA RPN=324 Yes

X4 Receptionist's skills set & education Fishbone Chart FMEA RPN=108 Yes

X5 Laboratory layout C&E Matrix FMEA RPN=54 No

X6 Patient demographics Historical Data FMEA RPN=9 No

ANALYZE

50

ANALYZE

51

ANALYZE

HYPOTHESIS TESTING

2 Sample t-Test and CI: Lab 8 - Process “A”, Lab 12 - Process “B”

The 2 sample t-test for Lab 8 - Process A vs. Lab 12 - Process B results:

N Mean St.Dev SE Mean

Lab 8 - Process A 12 880.00 5.06 1.5

Lab 12 - Process B 12 1089.00 1.13 0.33

Difference = µ (Lab 8 - Process A) - µ (Lab 12 - Process B)

Estimate for difference: -209.00

95% CI for difference: (-212.26, -205.74)

H0: µ 1 - µ 2 = δ0 versus H1: µ 1 - µ 2 ≠ δ0

t-test of difference = 0 (vs. not =): T-Value = -139.57 P-Value = 0.000 DF = 12

Power of the test: 1-β = 0.854

Conclusions:

The p-value=0.00 risk=0.05 , the null hypothesis H0 is rejected in favor of the alternative hypothesis H1 . The mean of data from process type A is statistically different from the mean of data from process type B.

52

ANALYZE

HYPOTHESIS TESTING

53

ANALYZE

HYPOTHESIS TESTING

54

Lab 12 - Process BLab 8 - Process A

1100

1050

1000

950

900

Dat

a

Boxplot of Lab 8 - Process A, Lab 12 - Process B

ANALYZE

IMPROVE

55

56

In Symbols In Words

HO D5=D8=D12 The differences in Blood Draw processes does not increase blood draws.

HA Not Ho The differences in Blood Draw processes does increase blood draws.

D=Blood Draws from labs 5, 8, & 12

ACTUAL SAMPLE DATA:

LAB 5: Number of items= 12

1188. 1190. 1191. 1194. 1196. 1200. 1200. 1204. 1206. 1209. 1210. 1212.

Mean = 1200

95% confidence interval for Mean: 1197. thru 1203.

Standard Deviation = 8.28

Hi = 1212 Low = 1188

Median = 1200

Average Absolute Deviation from Median = 6.83

LAB 8: Number of items= 12

870. 875. 876. 878. 880. 880. 880. 882. 882. 882. 885. 890.

Mean = 880.

95% confidence interval for Mean: 876.7 thru 883.3

Standard Deviation = 5.06

Hi = 890. Low = 870.

Median = 880.

Average Absolute Deviation from Median = 3.50

ANOVA ANALYSIS

IMPROVE

57

LAB 12: Number of items= 12

1087. 1088. 1088. 1089. 1089. 1089. 1089. 1089. 1089. 1089. 1091. 1091.

Mean= 1089

95% confidence interval for Mean: 1086. thru 1092.

Standard Deviation = 1.13

Hi = 1091 Low = 1087

Median = 1089

Average Absolute Deviation from Median = 0.667

ANOVA RESULTS:

Source of Sum of d.f. Mean F

Variation Squares Squares

between 633,610 2 316,800 9957.

within 1050. 33 31.82

total 634,660 35

The probability of this result, assuming the null hypothesis (Ho), p is = 0.000

The Decision:

Since Fobs (9957) is > Fcrit (3.29) [p=0], reject Ho and conclude that the differences

in blood draw processes does increase total blood draw throughput.

ANOVA ANALYSIS

IMPROVE

58

ANOVA ANALYSIS

IMPROVE

59

ANOVA ANALYSIS

IMPROVE

60

MEASUREMENT SYSTEM ANALYSIS (MSA)

Purpose:

Ensure that the difference in the Laboratory data is due to

actual differences in what is being measured, and not

variation in the measurement methods.

Conclusions:

The number of blood draws completed is calculated based

on actual Lab study results;

High level observed data was verified against detailed

weekly Lab output studies;

No significant difference was observed between weekly detail

data and monthly high level data;

Monthly high level data accurately represents output of the

Labs.

IMPROVE

61

PROCESS CAPABILITY

Tests

Opportunities

per test

Total

Opportunities Defects DPO DPMO P(good) Z long term Z short term Ppk Cpk

11,809 1 11,809 259.1 0.0219 21,941 0.9781 2.015 3.515 0.672 1.172

Tests

Opportunities

per test

Total

Opportunities Defects DPO DPMO P(good) Z long term Z short term Ppk Cpk

11,809 1 11,809 2,591 0.2194 219,409 0.7806 0.774 2.274 0.258 0.758

Tests

Opportunities

per test

Total

Opportunities Defects DPO DPMO P(good) Z long term Z short term Ppk Cpk

11,809 1 11,809 1295,5 0.1097 109,704 0.8903 1.228 2.728 0.409 0.909

The baseline:

The 50% improvement:

The 90% improvement:

IMPROVE

Potential Cause(s) Occurrence Recommended Action(s)

Receptionist training has not been

standardized across all labs

9 Observe & document duties for

receptionist in Lab 5 and cross train in the

other 11 labs

Applicant pool for receptionist

position varies

6 Raise the minimum required education

level

Receptionist never advised to

increase patient numbers

6 All lab personnel need to strive for 50

blood draws/day

No consistent company employee

established process/procedures

6 Tri-Core Medical Employee handbooks

need to be developed incorporating

enhanced redeptionist duties &

responsibilities

Commercial space availability &

cost/sq. ft.

3 Make sure all labs have a pleasing

environment and are wheel chair

accessible

Labs located closer to Senior

Centers and Assisted Living

facilities

1 Consider a mobile lab to help older

patients in specific areas of need

Modified FMEA

62

IMPROVE

CONTROL

PROCESS CONTROL:

1. Maintain two-week control charts for each lab,

and use 50 blood draws/day as a lower spec.

2. Have Monday morning meetings with all lab

personnel to discuss previous weeks results.

Make necessary improvements as needed.

3. Update employee handbooks for current policies

and procedures.

4. Hold quarterly Kaizen events to discuss overall

progress and identify other areas of

improvement.

63

Example Control Chart:

64

1 2 3 4 5 6 7 8 9 10 11 12

Daily Completed Blood Draws 45 48 41 43 37 49 42 48 39 41 45 50

Level 1 Tests 23 24 21 22 19 25 21 24 20 21 23 25

Level 2 Tests 14 14 12 13 11 15 13 14 12 12 14 15

Level 3 Tests 9 10 8 9 7 10 8 10 8 8 9 10

0

10

20

30

40

50

60

70

Dail

y B

loo

d D

raw

s

2-Week Laboratory Control Chart

Theoretical Maximum Lab 5 Performance

Current 11 Labs Performance

DAYS

CONTROL

65

CONTROL PLAN

Process Process Input Output Process Cpk / Measurement % R&R Control Who ? Where ? When ? Reaction

step specification Ppk system method plan

Blood Pre-24 hour Appointment list / Next day's schedule / N/A N/A Visual check N/A Self - Receptionist Schedule Beginning Check

draw advance call Voice mails/E-mails / Wait list / checking list of each per SOP

process to patient Active phone line Reschedule patients day reference

Blood Patient arrival Sign-in lab forms / Confirm test / N/A N/A Visual check N/A Self - Receptionist Patient After Check

draw and check-in ID card (document) / Pull patient chart / checking chart every per SOP

process Med. insurance card Patient prepared sign-in reference

Blood Blood draw 2nd ID verification / Label specimen vials LSL = N/A Cpk=0.5 Syringes, vials, 92.02% Counting Lab Patient After Check

draw completion Triage patient Patient released / USL = 66.5 Ppk=0 test strips technician 1 chart every per SOP

process (weight, general info) Specimens submitted [ draws / day ] draw reference

Blood Blood sample Labeled specimen Specimens grouped, LSL = N/A Cpk=0.5 Microscopes, 92.02% Counting Lab Testing After Check

draw analysis and vials with blood processed, recorded / USL = 66.5 Ppk=0 analysis technician 2 report every per SOP

process processing sample Testing reports out [ draws / day ] instruments recording reference

Blood Lab area Remove the Notify receptionist / N/A N/A Visual check N/A Self - Lab The lab End of Check

draw prepared for medical waste bins / Next patient charts / checking technician 1 area each per SOP

process next patient Prepare instruments Patient prepared and 2 test reference

Blood Next day's lab Dirty lab rooms / Cleaned-up lab / N/A N/A Visual check N/A Self - Receptionist The lab End of Check

draw preparation Empty bins without Replenish the bins / checking and Lab area each per SOP

process medical supplies New appointments technicians day reference

CONTROL

66

CONTROL

67

CONTROL

68

1. Print patient schedule / appointment list.

2. Clear voice mails from last evening.

3. Remove forwarding to emergency line.

4. Pull patient charts.

5. Confirm appointments for following day (call to confirm date and

time, re-schedule cancellation, start waiting list, update daily

schedule with wait listed patient confirmed).

6. Check-in patients (sign-in, confirm test, insurance card update).

7. Triage patient (weight, general information of visit).

8. Take sample (when possible).

9. Perform test (when possible).

10. Patient release (payment, next schedule, work / school excuse).

11. Clean lab rooms.

12. Call next patient for lab work.

13. Create tomorrow lab work (patient schedule / appointment list).

Receptionist’s Work Instruction:

CONTROL